Three imperatives that will help make regenerative medicine part of everyday medicine explained. By Juliana Blum, Humacyte cellandgene.com/doc/three-impe…

On a recent episode of Cell & Gene: The Podcast, Dr. Carl June and I discussed the future of solid tumors. cellandgene.com/doc/glimmers-o…

The field of cell therapy is at an exciting inflection point, with the convergence of increasingly precise gene-editing tools and the growing understanding of immunology. By Century Therapeutics #celltherapy #geneeding cellandgene.com/doc/the-challe…

#CellAndGenePodcast is brought to you by Cell&Gene in partnership with Applied Biosystems Check out the latest episode featuring @NovartisGene President, Chris Fox. #Novartis #SpinalMuscularAtrophy cellandgene.com/doc/commercial…

This article reviews the main cell technologies currently being developed in clinical research, including examples of studies being conducted, developers, modes of action, and benefits of the different types of cell therapies. By PA Consulting cellandgene.com/doc/car-t-beyo…

With 20+ #genetherapy targets in Novartis Gene Therapies’ pipeline, President Chris Fox and her team are hyper-focused on newborn screenings as the pathway to helping more and more patients. cellandgene.com/doc/commercial…

When it comes to aseptic processing, Michael Blackton and John Lee shared the critical elements to success. cellandgene.com/doc/but-what-a…

#CellAndGenePodcast is brought to you by Cell&Gene in partnership with Applied Biosystems. Check out the latest episode featuring @SernovaCorp CEO, Dr. Philip Toleikis. $SEOVF #diabetes cellandgene.com/doc/a-stem-cel…

#CGT, The Value Chain, And The Central Role Of The #patientsafety cellandgene.com/doc/cgt-the-va… via Cell&Gene Cardinal Health #advancetherapy #data #supplychain #celltheraphy #gentherapy #patients

Kite Pharma's Will Junker talks to #CellAndGenePodcast about the challenges associated with capacity planning, whether to partner with a CDMO, and more. In partnership with Applied Biosystems by Thermo Fisher Scientific. cellandgene.com/doc/planning-f…

With 20+ #genetherapy targets in Novartis Gene Therapies’ pipeline, President Chris Fox and her team are hyper-focused on newborn screenings as the pathway to helping more and more patients. cellandgene.com/doc/commercial…

#CellAndGenePodcast is brought to you by Cell&Gene in partnership with Applied Biosystems Check out the latest episode featuring @NovartisGene President, Chris Fox. #Novartis #SpinalMuscularAtrophy cellandgene.com/doc/commercial…

Walter Strapps, CEO of Carver Biosciences, Inc. states that when it comes to #mRNA, the challenges associated with its delivery are anything but new. cellandgene.com/doc/the-not-so…

Dr. Murat Kalayoglu, CEO, Cartesian Therapeutics explains that Cartesian ensures that the cells it administers, and therefore the RNA therapeutics that it administers, meet all the specifications the company sets forth in advance. cellandgene.com/doc/the-cell-a…

CGT manufacturers that deprioritize cybersecurity efforts risk their ecosystem being vulnerable to cyber-attacks that can adversely impact their business and the patients they serve. By Accenture cellandgene.com/doc/securing-c…

With 20+ #genetherapy targets in Novartis Gene Therapies’ pipeline, President Chris Fox and her team are hyper-focused on newborn screenings as the pathway to helping more and more patients. cellandgene.com/doc/commercial…

Kite Pharma's Will Junker talks to #CellAndGenePodcast about the challenges associated with capacity planning, whether to partner with a CDMO, and more. In partnership with Applied Biosystems by Thermo Fisher Scientific. cellandgene.com/doc/planning-f…

On #CellAndGenePodcast, ArrowheadPharma CMO Javier San Martin shares the roadmap for #RNAi as well as the company's pipeline development strategy, which includes pre-clinical to Phase 3 trials. In partnership with Applied Biosystems. cellandgene.com/doc/inside-rna…

CGT manufacturers that deprioritize cybersecurity efforts risk their ecosystem being vulnerable to cyber-attacks that can adversely impact their business and the patients they serve. By Accenture cellandgene.com/doc/securing-c…

Walter Strapps, CEO of Carver Biosciences, Inc. states that when it comes to #mRNA, the challenges associated with its delivery are anything but new. cellandgene.com/doc/the-not-so…